The Versatility of Beta-D-Ribofuranose 1,2,3,5-Tetraacetate in Nucleoside Chemistry
While Beta-D-Ribofuranose 1,2,3,5-Tetraacetate (CAS 13035-61-5) is widely recognized for its crucial role in the synthesis of the antiviral drug Ribavirin, its versatility extends into broader areas of nucleoside chemistry and pharmaceutical research. Ningbo Inno Pharmchem Co., Ltd. is proud to supply this essential intermediate, enabling advancements across various scientific disciplines.
The structure of Beta-D-Ribofuranose 1,2,3,5-Tetraacetate, a protected form of D-ribose, makes it an ideal starting material for a multitude of nucleoside analogs. Nucleosides are fundamental biological molecules that form the backbone of DNA and RNA. Synthetic nucleoside derivatives have proven to be powerful therapeutic agents, particularly as antiviral and anticancer drugs, by interfering with viral replication or DNA synthesis.
When pharmaceutical companies choose to buy Beta-D-Ribofuranose 1,2,3,5-Tetraacetate, they are not only securing a key component for Ribavirin production but also accessing a versatile building block for broader drug discovery programs. The acetyl groups on the ribose molecule can be selectively removed or modified, allowing for the introduction of various bases or other functional groups, leading to a diverse range of nucleoside compounds. This adaptability is highly valued in research and development settings.
As a dedicated CAS 13035-61-5 supplier, Ningbo Inno Pharmchem Co., Ltd. ensures that this intermediate meets the high standards required for such sensitive synthetic applications. The consistent purity and reliable availability of Tetraacetylribofuranose are critical for researchers exploring new antiviral agents, chemotherapy drugs, or even diagnostic tools that utilize nucleoside chemistry. The pharmaceutical use of this compound is a testament to its foundational importance in creating molecules that interact with biological systems.
Ningbo Inno Pharmchem Co., Ltd. remains committed to supporting innovation in nucleoside chemistry and drug development by providing high-quality Beta-D-Ribofuranose 1,2,3,5-Tetraacetate. We understand that our role as a CAS 13035-61-5 supplier is integral to the progress of pharmaceutical research, enabling scientists to explore new therapeutic avenues and create next-generation treatments.
Perspectives & Insights
Future Origin 2025
“The pharmaceutical use of this compound is a testament to its foundational importance in creating molecules that interact with biological systems.”
Core Analyst 01
“remains committed to supporting innovation in nucleoside chemistry and drug development by providing high-quality Beta-D-Ribofuranose 1,2,3,5-Tetraacetate.”
Silicon Seeker One
“We understand that our role as a CAS 13035-61-5 supplier is integral to the progress of pharmaceutical research, enabling scientists to explore new therapeutic avenues and create next-generation treatments.”